Form 4: Delcath Systems Director Modifies Stock Option Terms
SEC Form 4
Roger G. Stoll, a director at Delcath Systems, amended several stock option grants to extend the post-termination exercise period.
Summary
- Roger G. Stoll, a director of Delcath Systems, Inc., filed a Form 4 on May 28, 2024, reporting changes in beneficial ownership.
- The reported transactions involve amendments to existing stock options to extend the post-termination exercise period.
- These amendments resulted in the deemed cancellation of the 'old' options and the grant of replacement options.
- The options were originally granted on various dates: February 1, 2019; November 23, 2020; August 5, 2021; May 4, 2022; and June 12, 2023.
- The amendments affect options with exercise prices of $196.7, $11.67, $10.16, $6.24, and $7.25.
- The total number of shares underlying these options is 142, 40,000, 9,000, 9,000 and 19,682 respectively.
- All the options are fully vested.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock option amendments, with no inherently positive or negative implications for the company's financial health or future prospects.
Positives
- The extension of the post-termination exercise period for stock options could be seen as a positive for the director, providing more flexibility in exercising the options.
Industry Context
Stock options are a common form of compensation for directors and executives in publicly traded companies. Amendments to option terms are not unusual and can be driven by various factors, including changes in company policy or individual circumstances.
Stakeholder Impact
- The amendment of stock options may have a minor impact on shareholders by potentially increasing the number of shares that could be issued in the future.
Key Dates
| Date | Description |
|---|---|
| 02/01/2019 | Original grant date of one of the stock option grants. |
| 12/24/2019 | Date of stock split affecting option share price. |
| 11/23/2020 | Original grant date of one of the stock option grants. |
| 08/05/2021 | Original grant date of one of the stock option grants. |
| 05/04/2022 | Original grant date of one of the stock option grants. |
| 06/12/2023 | Original grant date of one of the stock option grants. |
| 05/23/2024 | Date of the reported transactions (amendment of stock options). |
| 05/28/2024 | Date of Form 4 filing. |
| 05/23/2026 | Expiration date of the replacement options. |
| 10/01/2030 | Expiration date of one of the stock option grants. |
| 08/05/2031 | Expiration date of one of the stock option grants. |
| 06/12/2033 | Expiration date of one of the stock option grants. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.